In Silico Design and Analysis of TGF&#945;L3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique.

Imani-Fooladi, Abbas Ali; Yousefi, Forough; Mousavi, Seyed Fazloallah; Amani, Jafar

In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique.

Imani-Fooladi, Abbas Ali; Yousefi, Forough; Mousavi, Seyed Fazloallah; Amani, Jafar.

Afiliação

Imani-Fooladi AA; Applied Microbiology Research center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Yousefi F; Dept. of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Mousavi SF; Dept. of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Amani J; Applied Microbiology Research center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Iran J Cancer Prev ; 7(3): 152-64, 2014.

Article em En | MEDLINE | ID: mdl-25250167

Palavras-chave

Cancer Immunotherapy, in silico modeling; Enterotoxin type B; Growth Factor α

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Iran J Cancer Prev Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Irã País de publicação: Irã

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google